Mark Oki
CFO
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Achieve Life Sciences, Inc. (ACHV) | Chief Financial Officer | $30,864 | $1,015,388 |
Executive changes
Earnings-call appearances
-
Achieve Life Sciences, Inc. Q4 FY2025 Earnings Call2026-03-24
Achieve Life Sciences, Inc. (ACHV)
-
Achieve Life Sciences, Inc. Q3 FY2025 Earnings Call2025-11-06
Achieve Life Sciences, Inc. (ACHV)
-
Achieve Life Sciences, Inc. Q2 FY2025 Earnings Call2025-08-07
Achieve Life Sciences, Inc. (ACHV)
-
Achieve Life Sciences, Inc. Q1 FY2025 Earnings Call2025-05-13
Achieve Life Sciences, Inc. (ACHV)
-
Achieve Life Sciences, Inc. Q4 FY2024 Earnings Call2025-03-11
Achieve Life Sciences, Inc. (ACHV)
-
Aytu Biopharma, Inc Q3 FY2024 Earnings Call2024-05-15
Aytu Biopharma, Inc (AYTU)
-
Aytu Biopharma, Inc Q1 FY2024 Earnings Call2023-11-14
Aytu Biopharma, Inc (AYTU)
-
Aytu Biopharma, Inc Q2 FY2023 Earnings Call2023-02-21
Aytu Biopharma, Inc (AYTU)
-
Aytu Biopharma, Inc Q4 FY2022 Earnings Call2022-09-28
Aytu Biopharma, Inc (AYTU)